(Q34107485)

31 July 2017

1 reference

title

Diet and pharmacologic therapy of obesity to modify atherosclerosis (English)

1 reference

31 July 2017

1 reference

Jones PH

1

1 reference

31 July 2017

publication date

1 July 2000

1 reference

Current Atherosclerosis Reports

31 July 2017

published in

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

314-320

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-000-0065-5

31 July 2017

exact match

0 references

cites work

Health implications of overweight and obesity in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0065-5

Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0065-5

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0065-5

Weight gain as a risk factor for clinical diabetes mellitus in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0065-5

Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0065-5

Reduction of visceral adipose tissue and improvement of metabolic indices: effect of dexfenfluramine in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0065-5

A double-blind randomized placebo-controlled trial of sibutramine

21 January 2018

1 reference

12 December 2020

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

1 reference

12 December 2020

American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee

1 reference

12 December 2020

Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis

1 reference

12 December 2020

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

12 December 2020

A prospective study of body mass index, weight change, and risk of stroke in women

1 reference

12 December 2020

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

1 reference

12 December 2020

Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects

1 reference

12 December 2020

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

1 reference

12 December 2020

Reduction of Serum Cholesterol with Sitostanol-Ester Margarine in a Mildly Hypercholesterolemic Population

1 reference

12 December 2020

A meta-analysis of the factors affecting exercise-induced changes in body mass, fat mass and fat-free mass in males and females

1 reference

12 December 2020

Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study

1 reference

12 December 2020

Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men.

1 reference

12 December 2020

Central obesity and coronary heart disease in men.

1 reference

12 December 2020

The disease burden associated with overweight and obesity

1 reference

12 December 2020

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study

1 reference

12 December 2020

Beneficial health effects of modest weight loss

1 reference

12 December 2020

Lifetime Health and Economic Consequences of Obesity

1 reference

12 December 2020

Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects.

1 reference

12 December 2020

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

12 December 2020

Body weight and mortality. A 27-year follow-up of middle-aged men.

1 reference

12 December 2020

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

1 reference

12 December 2020

Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease

1 reference

12 December 2020

Dexfenfluramine as an adjunct to a reduced-fat, ad libitum diet: effects on body composition, nutrient intake and cardiovascular risk factors

1 reference

12 December 2020

Overweight and obesity in the United States: prevalence and trends, 1960-1994

1 reference

12 December 2020

Effect of dexfenfluramine treatment on body weight, blood pressure and noradrenergic activity in obese hypertensive patients

1 reference

12 December 2020

An eight-year experience with a very-low-calorie formula diet for control of major obesity

1 reference

12 December 2020

Effect of dexfenfluramine on body weight, blood pressure, insulin resistance and serum cholesterol in obese individuals

1 reference

12 December 2020

Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid

1 reference

12 December 2020

American Diabetes Association: clinical practice recommendations 1999

1 reference

12 December 2020

Weight loss and plasma lipids.

1 reference

12 December 2020

The spread of the obesity epidemic in the United States, 1991-1998

1 reference

12 December 2020

Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study

1 reference

12 December 2020

Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years

1 reference

12 December 2020

Valvular heart disease associated with fenfluramine-phentermine

1 reference

12 December 2020

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

1 reference

12 December 2020

Exercise as an adjunct to weight loss and maintenance in moderately obese subjects

1 reference

12 December 2020

Variations in mortality by weight among 750,000 men and women

1 reference

12 December 2020

Health implications of obesity. National Institutes of Health Consensus Development Conference Statement

1 reference

12 December 2020

The treatment of mild hypertension study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. The Treatment of Mild Hypertension Research Group

1 reference

12 December 2020

Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range

1 reference

12 December 2020

Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men.

1 reference

12 December 2020

Regional obesity and risk of cardiovascular disease; the Framingham Study

1 reference

12 December 2020

Body weight and longevity. A reassessment

1 reference

12 December 2020

Use of drugs in the treatment of obesity

1 reference

12 December 2020

Dexfenfluramine reduces cardiovascular risk factors

1 reference

12 December 2020

Effect of Weight Loss without Salt Restriction on the Reduction of Blood Pressure in Overweight Hypertensive Patients

1 reference

12 December 2020

Obesity and body fat distribution in relation to the incidence of non-insulin-dependent diabetes mellitus. A prospective cohort study of men in the normative aging study

1 reference

12 December 2020

10.1007/S11883-000-0065-5

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1037416689

0 references

1 reference